Literature DB >> 16450767

Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement.

M Tucci1, C Quatraro, F Silvestris.   

Abstract

Sjorgen's syndrome (SS) is an autoimmune exocrinopathy characterized by lymphocyte infiltration of salivary and lacrimal glands that leads to progressive xerostomia and xerophtalmia. One-third of patients suffer of systemic manifestations including arthritis, fever, fatigue and mucosal dryness whereas those with major salivary involvement show an increased risk to develop low-grade non-Hpdgkin lymphomas. In addition, a minority of patients show symptoms related to progressive hearing loss whose pathogenesis remains undefined. Both deposition of autoantibodies to antigens of the inner-ear structures and infiltration by autoreactive T-cells have been implicated in its pathogenesis. In this context, high levels of autoantibodies to both cardiolipin and M3 muscarinic receprtors as well as to ciliar epitopes of the cochlear cells have been recently described. Here we review recent advances on the pathodgenesis of SS with a particular focus to otolaryngological manifestations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16450767      PMCID: PMC2639870     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  27 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.

Authors:  J D Reveille; M J Macleod; K Whittington; F C Arnett
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

Review 3.  Genetic studies in Sjögren's syndrome and systemic lupus erythematosus.

Authors:  F C Arnett; W B Bias; J D Reveille
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

4.  CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells.

Authors:  Henry Y Dong; Aliakbar Shahsafaei; David M Dorfman
Journal:  Leuk Lymphoma       Date:  2002-09

5.  Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.

Authors:  Vidya Sankar; Michael T Brennan; Marc R Kok; Rose Anne Leakan; Janine A Smith; Joan Manny; Bruce J Baum; Stanley R Pillemer
Journal:  Arthritis Rheum       Date:  2004-07

6.  The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.

Authors:  J Font; M García-Carrasco; M Ramos-Casals; A I Aldea; R Cervera; M Ingelmo; J Vives; J Yagüe
Journal:  Rheumatology (Oxford)       Date:  2002-09       Impact factor: 7.580

7.  Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.

Authors:  Martin J Cummins; Athena Papas; Gary M Kammer; Philip C Fox
Journal:  Arthritis Rheum       Date:  2003-08-15

8.  [High-dose intravenous immunoglobulin in the treatment of sensory ataxic neuropathy with Sjögren's syndrome: a case report].

Authors:  Yoshiharu Taguchi; Shutaro Takashima; Maiko Takata; Nobuhiro Dougu; Etsuko Asaoka; Hiroshi Inoue
Journal:  No To Shinkei       Date:  2004-05

9.  [Is the target of anti-cardiolipin antibodies the same in Gougerot-Sjögren syndrome and lupus erythematosus disseminatus?].

Authors:  J F Moysan; J Jouquan; C Gérard; Y Pennec; P Le Goff; P Youinou
Journal:  Rev Med Interne       Date:  1987 Mar-Apr       Impact factor: 0.728

10.  Water-soluble GTP-binding protein from rat olfactory epithelium.

Authors:  V I Novoselov; I V Peshenko; V J Evdokimov; J V Nikolaev; E A Matveeva; E E Fesenko
Journal:  FEBS Lett       Date:  1994-10-24       Impact factor: 4.124

View more
  10 in total

1.  Extended high-frequency audiometry as early detection of hearing loss in primary Sjögren syndrome.

Authors:  José Luis Treviño González; Janett Riega Torres; Yolisa Hinojosa Ríos; Mario Jesús Villegas González; Marco A Mendez Saenz; German A Soto-Galindo
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

2.  Successful treatment of sensorineural hearing loss in Sjögren's syndrome with corticosteroid.

Authors:  Ki-Sik Kim; Hyun-Sook Kim
Journal:  Korean J Intern Med       Date:  2016-04-08       Impact factor: 2.884

Review 3.  Audiovestibular Symptoms in Systemic Autoimmune Diseases.

Authors:  Massimo Ralli; Vittorio D'Aguanno; Arianna Di Stadio; Armando De Virgilio; Adelchi Croce; Lucia Longo; Antonio Greco; Marco de Vincentiis
Journal:  J Immunol Res       Date:  2018-08-19       Impact factor: 4.818

Review 4.  Laryngological manifestations of Sjögren's syndrome.

Authors:  Bartłomiej Kamiński
Journal:  Reumatologia       Date:  2019-02-28

5.  Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model.

Authors:  Deniz Genç; Osman Bulut; Burcu Günaydin; Mizgin Göksu; Mert Düzgün; Yelda Dere; Serhat Sezgin; Akın Aladağ; Aziz Bülbül
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

Review 6.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25

Review 7.  Sensorineural Hearing Loss in Sjögren's Syndrome.

Authors:  Yuko Okawa; Kenji Ihara
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

Review 8.  Recent Advances in Mouse Models of Sjögren's Syndrome.

Authors:  Yunzhen Gao; Yan Chen; Zhongjian Zhang; Xinhua Yu; Junfeng Zheng
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 9.  Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Authors:  Valerie Hox; Evelijn Lourijsen; Arnout Jordens; Kristian Aasbjerg; Ioana Agache; Isam Alobid; Claus Bachert; Koen Boussery; Paloma Campo; Wytske Fokkens; Peter Hellings; Claire Hopkins; Ludger Klimek; Mika Mäkelä; Ralph Mösges; Joaquim Mullol; Laura Pujols; Carmen Rondon; Michael Rudenko; Sanna Toppila-Salmi; Glenis Scadding; Sophie Scheire; Peter-Valentin Tomazic; Thibaut Van Zele; Martin Wagemann; Job F M van Boven; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2020-01-03       Impact factor: 5.871

10.  Brainstem auditory evoked potentials in patients with primary Sjögren's syndrome without central nervous system involvement.

Authors:  Marta Waliszewska-Prosół; Agata Sebastian; Piotr Wiland; Sławomir Budrewicz; Edyta Dziadkowiak; Maria Ejma
Journal:  Clin Rheumatol       Date:  2020-08-18       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.